These results suggest that GDF15 gene editing therapy using nanocapsules significantly enhanced the immune infiltration of CD8+ cytotoxic T lymphocytes, NK cells, and M1 macrophages, but reduced the immune infiltration of M2 macrophages, thereby improving the tumor immune microenvironment and promoting tumor immune killing. Here, GDF15 is linked to neoplasm.